KYOWA HAKKO KIRIN CO., LTD.;ULTRAGENYX PHARMACEUTICAL INC.
发明人:
KAKKIS, EMIL,SAN MARTIN, JAVIER,SUDO, TOMOHIRO
申请号：
CA2949234
公开号：
CA2949234A1
申请日:
2015.05.29
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.
